Amedisys Stock Price and Value Analysis

Should you buy Amedisys stock? (NasdaqGS:AMED). Let's see how it does in our automated value investing analysis system.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Amedisys to reach your target.

Target type

AMED Free Cash Flow Trend

Free Cash Flow trendline for AMED
Free Cash Flow trendline for Amedisys
CSV

Based on historical returns, we believe that Amedisys can grow its free cash at a rate of about 3%. That's positive!

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This company has wild ups and downs.
  • This company is making money at a modest rate.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the AMED Numbers

AMED Price
(Amedisys stock price per share)
$84.03
[?] AMED Fair Price
(based on intrinsic value)
$24.82
[?] AMED Safety Price (based on a variable margin of safety) $16.13
[?] PE Ratio versus Sector 31% lower than other Healthcare stocks
[?] PE Ratio versus Industry 42% lower than other Home Health Care stocks
[?] Free Cash Flow Jitter 65%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 2,035,583 shares shorted. With 31,902,964 shares available for purchase and an average trading volume over the past 10 trading days of 353,050, it would take at least 5.766 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Is Amedisys Stock on Sale?

We believe that Amedisys may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Amedisys looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Advertisement supports free stock analysis content.

Should You Buy AMED Stock?

Does Amedisys have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: AMED

This example shows how we apply the Trendshare checklist to AMED: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 84.03
    • Market cap: $2.7B
    • EPS: 6.059
  2. Step 2 — Valuation checks

    • P/E: 13.87
    • FCF yield: —
    • Date checked: Jul 26, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.

Most Popular Articles